nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—PTGS2—melanoma	0.7	1	CbGaD
Drospirenone—Cerebral infarction—Carmustine—melanoma	0.00637	0.0944	CcSEcCtD
Drospirenone—Thromboembolic event—Docetaxel—melanoma	0.00495	0.0734	CcSEcCtD
Drospirenone—PTGS2—leg—melanoma	0.00463	0.112	CbGeAlD
Drospirenone—PTGS2—hindlimb—melanoma	0.00414	0.0996	CbGeAlD
Drospirenone—PGR—blood vessel—melanoma	0.00396	0.0952	CbGeAlD
Drospirenone—PTGS2—appendage—melanoma	0.00355	0.0854	CbGeAlD
Drospirenone—Embolism—Temozolomide—melanoma	0.00313	0.0463	CcSEcCtD
Drospirenone—PTGS2—skin epidermis—melanoma	0.00295	0.0711	CbGeAlD
Drospirenone—Thrombosis—Carmustine—melanoma	0.00293	0.0435	CcSEcCtD
Drospirenone—Breast pain—Temozolomide—melanoma	0.0023	0.0341	CcSEcCtD
Drospirenone—NR3C2—retina—melanoma	0.00224	0.054	CbGeAlD
Drospirenone—PTGS2—endothelium—melanoma	0.00214	0.0516	CbGeAlD
Drospirenone—Embolism—Docetaxel—melanoma	0.00208	0.0308	CcSEcCtD
Drospirenone—Testosterone Propionate—CYP17A1—melanoma	0.00204	0.296	CrCbGaD
Drospirenone—PTGS2—blood vessel—melanoma	0.00198	0.0476	CbGeAlD
Drospirenone—Erythema multiforme—Vemurafenib—melanoma	0.00186	0.0276	CcSEcCtD
Drospirenone—NR3C2—mammalian vulva—melanoma	0.0018	0.0433	CbGeAlD
Drospirenone—Angiopathy—Vemurafenib—melanoma	0.00179	0.0265	CcSEcCtD
Drospirenone—Cerebrovascular accident—Bleomycin—melanoma	0.00176	0.0261	CcSEcCtD
Drospirenone—AR—skin of body—melanoma	0.00146	0.0351	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00145	0.0215	CcSEcCtD
Drospirenone—Affect lability—Temozolomide—melanoma	0.00143	0.0212	CcSEcCtD
Drospirenone—Mood swings—Temozolomide—melanoma	0.00138	0.0205	CcSEcCtD
Drospirenone—Nervous system disorder—Vemurafenib—melanoma	0.00137	0.0204	CcSEcCtD
Drospirenone—Skin disorder—Vemurafenib—melanoma	0.00136	0.0202	CcSEcCtD
Drospirenone—AR—mammalian vulva—melanoma	0.00133	0.032	CbGeAlD
Drospirenone—Breast disorder—Temozolomide—melanoma	0.00132	0.0195	CcSEcCtD
Drospirenone—Acute coronary syndrome—Bleomycin—melanoma	0.00131	0.0194	CcSEcCtD
Drospirenone—Myocardial infarction—Bleomycin—melanoma	0.0013	0.0193	CcSEcCtD
Drospirenone—NR3C2—head—melanoma	0.00129	0.031	CbGeAlD
Drospirenone—Gastrointestinal disorder—Vemurafenib—melanoma	0.00121	0.0179	CcSEcCtD
Drospirenone—Haemoglobin—Bleomycin—melanoma	0.0012	0.0178	CcSEcCtD
Drospirenone—PGR—head—melanoma	0.00119	0.0288	CbGeAlD
Drospirenone—Haemorrhage—Bleomycin—melanoma	0.00119	0.0177	CcSEcCtD
Drospirenone—BCHE—skin of body—melanoma	0.00119	0.0286	CbGeAlD
Drospirenone—Depression—Carmustine—melanoma	0.00116	0.0172	CcSEcCtD
Drospirenone—Depression—Temozolomide—melanoma	0.00112	0.0166	CcSEcCtD
Drospirenone—BCHE—mammalian vulva—melanoma	0.00108	0.0261	CbGeAlD
Drospirenone—Erythema multiforme—Dactinomycin—melanoma	0.00105	0.0156	CcSEcCtD
Drospirenone—Haemoglobin—Carmustine—melanoma	0.00105	0.0155	CcSEcCtD
Drospirenone—Haemorrhage—Carmustine—melanoma	0.00104	0.0155	CcSEcCtD
Drospirenone—Haemoglobin—Temozolomide—melanoma	0.00101	0.015	CcSEcCtD
Drospirenone—Haemorrhage—Temozolomide—melanoma	0.00101	0.0149	CcSEcCtD
Drospirenone—Migraine—Docetaxel—melanoma	0.000953	0.0141	CcSEcCtD
Drospirenone—Erythema multiforme—Temozolomide—melanoma	0.000953	0.0141	CcSEcCtD
Drospirenone—AR—head—melanoma	0.000952	0.0229	CbGeAlD
Drospirenone—Progesterone—CYP17A1—melanoma	0.000934	0.136	CrCbGaD
Drospirenone—PTGS2—skin of body—melanoma	0.000914	0.022	CbGeAlD
Drospirenone—Angiopathy—Temozolomide—melanoma	0.000914	0.0136	CcSEcCtD
Drospirenone—Mental disorder—Carmustine—melanoma	0.000914	0.0135	CcSEcCtD
Drospirenone—NR3C2—lymph node—melanoma	0.0009	0.0217	CbGeAlD
Drospirenone—Mental disorder—Temozolomide—melanoma	0.000883	0.0131	CcSEcCtD
Drospirenone—Breast disorder—Docetaxel—melanoma	0.000875	0.013	CcSEcCtD
Drospirenone—PGR—lymph node—melanoma	0.000837	0.0201	CbGeAlD
Drospirenone—Nausea—Vemurafenib—melanoma	0.000832	0.0123	CcSEcCtD
Drospirenone—BCHE—head—melanoma	0.000774	0.0186	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000742	0.011	CcSEcCtD
Drospirenone—Acute coronary syndrome—Docetaxel—melanoma	0.000736	0.0109	CcSEcCtD
Drospirenone—Myocardial infarction—Docetaxel—melanoma	0.000732	0.0108	CcSEcCtD
Drospirenone—Nervous system disorder—Temozolomide—melanoma	0.000702	0.0104	CcSEcCtD
Drospirenone—Skin disorder—Temozolomide—melanoma	0.000695	0.0103	CcSEcCtD
Drospirenone—Haemoglobin—Docetaxel—melanoma	0.000674	0.00998	CcSEcCtD
Drospirenone—Haemorrhage—Docetaxel—melanoma	0.00067	0.00993	CcSEcCtD
Drospirenone—AR—lymph node—melanoma	0.000667	0.016	CbGeAlD
Drospirenone—Progesterone—CYP1B1—melanoma	0.000648	0.0943	CrCbGaD
Drospirenone—Gastrointestinal disorder—Carmustine—melanoma	0.00064	0.00948	CcSEcCtD
Drospirenone—Erythema multiforme—Docetaxel—melanoma	0.000634	0.00939	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Temozolomide—melanoma	0.000618	0.00916	CcSEcCtD
Drospirenone—Testosterone—CYP1B1—melanoma	0.000612	0.0891	CrCbGaD
Drospirenone—Angiopathy—Docetaxel—melanoma	0.000608	0.00901	CcSEcCtD
Drospirenone—PTGS2—head—melanoma	0.000597	0.0144	CbGeAlD
Drospirenone—Mental disorder—Docetaxel—melanoma	0.000587	0.0087	CcSEcCtD
Drospirenone—Megestrol acetate—ABCB1—melanoma	0.000552	0.0804	CrCbGaD
Drospirenone—BCHE—lymph node—melanoma	0.000542	0.0131	CbGeAlD
Drospirenone—Nausea—Bleomycin—melanoma	0.000504	0.00747	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000493	0.00731	CcSEcCtD
Drospirenone—Nausea—Dactinomycin—melanoma	0.00047	0.00697	CcSEcCtD
Drospirenone—Nervous system disorder—Docetaxel—melanoma	0.000467	0.00692	CcSEcCtD
Drospirenone—Skin disorder—Docetaxel—melanoma	0.000462	0.00685	CcSEcCtD
Drospirenone—Nausea—Carmustine—melanoma	0.00044	0.00652	CcSEcCtD
Drospirenone—Nausea—Temozolomide—melanoma	0.000425	0.0063	CcSEcCtD
Drospirenone—PTGS2—lymph node—melanoma	0.000418	0.0101	CbGeAlD
Drospirenone—Gastrointestinal disorder—Docetaxel—melanoma	0.000411	0.00609	CcSEcCtD
Drospirenone—Spironolactone—ABCB1—melanoma	0.000343	0.05	CrCbGaD
Drospirenone—Norethindrone—ALB—melanoma	0.000334	0.0486	CrCbGaD
Drospirenone—Norethindrone—ABCB1—melanoma	0.000319	0.0464	CrCbGaD
Drospirenone—Methyltestosterone—ALB—melanoma	0.000317	0.0462	CrCbGaD
Drospirenone—Nausea—Docetaxel—melanoma	0.000283	0.00419	CcSEcCtD
Drospirenone—Hydrocortisone—ABCB1—melanoma	0.000228	0.0332	CrCbGaD
Drospirenone—Progesterone—ABCB1—melanoma	0.000186	0.0271	CrCbGaD
Drospirenone—Testosterone—ALB—melanoma	0.000184	0.0268	CrCbGaD
Drospirenone—Testosterone—ABCB1—melanoma	0.000176	0.0256	CrCbGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IL6—melanoma	8.34e-05	0.000453	CbGpPWpGaD
Drospirenone—PTGS2—Disease—LUM—melanoma	8.31e-05	0.000452	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—VDR—melanoma	8.2e-05	0.000446	CbGpPWpGaD
Drospirenone—BCHE—Transmission across Chemical Synapses—MAPK1—melanoma	8.18e-05	0.000445	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TNF—melanoma	8.17e-05	0.000444	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HPSE—melanoma	8.15e-05	0.000443	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIP4K2A—melanoma	8.03e-05	0.000436	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLC6A11—melanoma	8.03e-05	0.000436	CbGpPWpGaD
Drospirenone—AR—Gene Expression—HDAC2—melanoma	8.02e-05	0.000436	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CUBN—melanoma	8e-05	0.000435	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—F2R—melanoma	7.96e-05	0.000433	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—MTAP—melanoma	7.81e-05	0.000425	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	7.8e-05	0.000424	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PLA2G6—melanoma	7.74e-05	0.000421	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CSPG4—melanoma	7.73e-05	0.00042	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EDNRB—melanoma	7.71e-05	0.000419	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	7.65e-05	0.000416	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	7.63e-05	0.000415	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RPS3—melanoma	7.6e-05	0.000413	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PRKCA—melanoma	7.56e-05	0.000411	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—ERCC2—melanoma	7.5e-05	0.000408	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTK2B—melanoma	7.48e-05	0.000407	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SKI—melanoma	7.48e-05	0.000407	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	7.44e-05	0.000405	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	7.37e-05	0.000401	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GNA11—melanoma	7.28e-05	0.000396	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GAB2—melanoma	7.28e-05	0.000396	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FLT1—melanoma	7.25e-05	0.000394	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TP53—melanoma	7.21e-05	0.000392	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	7.2e-05	0.000391	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	7.2e-05	0.000391	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	7.18e-05	0.000391	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	7.15e-05	0.000389	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PHGDH—melanoma	6.96e-05	0.000378	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—LUM—melanoma	6.96e-05	0.000378	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—VCAN—melanoma	6.95e-05	0.000378	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HDAC2—melanoma	6.84e-05	0.000372	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FOXO4—melanoma	6.84e-05	0.000372	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCR4—melanoma	6.84e-05	0.000372	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HPSE—melanoma	6.82e-05	0.000371	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—MYC—melanoma	6.77e-05	0.000368	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GNAQ—melanoma	6.77e-05	0.000368	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CUBN—melanoma	6.7e-05	0.000364	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL6—melanoma	6.6e-05	0.000359	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	6.58e-05	0.000358	CbGpPWpGaD
Drospirenone—BCHE—Transmission across Chemical Synapses—HRAS—melanoma	6.56e-05	0.000357	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MMP1—melanoma	6.51e-05	0.000354	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	6.49e-05	0.000353	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SDHD—melanoma	6.47e-05	0.000352	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—BSG—melanoma	6.47e-05	0.000352	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CSPG4—melanoma	6.47e-05	0.000352	CbGpPWpGaD
Drospirenone—AR—Gene Expression—CDKN2B—melanoma	6.41e-05	0.000348	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SYK—melanoma	6.36e-05	0.000346	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.35e-05	0.000345	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GPAM—melanoma	6.27e-05	0.000341	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—MAPK1—melanoma	6.27e-05	0.000341	CbGpPWpGaD
Drospirenone—AR—Gene Expression—VDR—melanoma	6.25e-05	0.00034	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ITGAV—melanoma	6.24e-05	0.00034	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKT3—melanoma	6.24e-05	0.00034	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NGFR—melanoma	6.24e-05	0.00034	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HDAC6—melanoma	6.18e-05	0.000336	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	6.14e-05	0.000334	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—NOTCH1—melanoma	6.06e-05	0.000329	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—melanoma	5.97e-05	0.000325	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP17A1—melanoma	5.87e-05	0.000319	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NPPA—melanoma	5.85e-05	0.000318	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	5.84e-05	0.000317	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	5.84e-05	0.000317	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.79e-05	0.000315	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SOCS1—melanoma	5.78e-05	0.000314	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—S100B—melanoma	5.77e-05	0.000314	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PRKCA—melanoma	5.76e-05	0.000313	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PPARG—melanoma	5.72e-05	0.000311	CbGpPWpGaD
Drospirenone—PTGS2—Disease—VCAN—melanoma	5.71e-05	0.000311	CbGpPWpGaD
Drospirenone—AR—Gene Expression—ERCC2—melanoma	5.71e-05	0.000311	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—ALB—melanoma	5.71e-05	0.000311	CbGpPWpGaD
Drospirenone—PTGS2—Disease—WNT5A—melanoma	5.67e-05	0.000308	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—melanoma	5.56e-05	0.000302	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GNA11—melanoma	5.54e-05	0.000301	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ERBB4—melanoma	5.52e-05	0.0003	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	5.52e-05	0.0003	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MAPK3—melanoma	5.5e-05	0.000299	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDKN2B—melanoma	5.47e-05	0.000297	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—FASN—melanoma	5.42e-05	0.000295	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MYC—melanoma	5.35e-05	0.000291	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SLC5A5—melanoma	5.33e-05	0.00029	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PLA2G6—melanoma	5.33e-05	0.00029	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CD86—melanoma	5.29e-05	0.000288	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EDN1—melanoma	5.25e-05	0.000285	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—IGF1—melanoma	5.21e-05	0.000283	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—MYC—melanoma	5.16e-05	0.00028	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GNAQ—melanoma	5.15e-05	0.00028	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CD44—melanoma	5.15e-05	0.00028	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGF1—melanoma	5.13e-05	0.000279	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CSF2—melanoma	5.13e-05	0.000279	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	5.07e-05	0.000276	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.04e-05	0.000274	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MMP2—melanoma	5.04e-05	0.000274	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—HRAS—melanoma	5.03e-05	0.000273	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—E2F1—melanoma	5.02e-05	0.000273	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5e-05	0.000272	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PDGFRA—melanoma	4.97e-05	0.00027	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP1B1—melanoma	4.94e-05	0.000268	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ITGB3—melanoma	4.92e-05	0.000267	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PRKCA—melanoma	4.92e-05	0.000267	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	4.9e-05	0.000267	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SPP1—melanoma	4.82e-05	0.000262	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAP2K2—melanoma	4.81e-05	0.000261	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—VCAN—melanoma	4.79e-05	0.00026	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NOTCH1—melanoma	4.61e-05	0.000251	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TERT—melanoma	4.57e-05	0.000249	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RAC1—melanoma	4.56e-05	0.000248	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GAB2—melanoma	4.55e-05	0.000248	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.53e-05	0.000246	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FASN—melanoma	4.46e-05	0.000242	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.37e-05	0.000238	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HIF1A—melanoma	4.37e-05	0.000238	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.36e-05	0.000237	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PPARG—melanoma	4.36e-05	0.000237	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HDAC2—melanoma	4.28e-05	0.000233	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FOXO4—melanoma	4.28e-05	0.000233	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CXCR4—melanoma	4.28e-05	0.000233	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD44—melanoma	4.23e-05	0.00023	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CXCL8—melanoma	4.19e-05	0.000228	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KDR—melanoma	4.18e-05	0.000227	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	4.14e-05	0.000225	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ABCB1—melanoma	4.07e-05	0.000221	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP17A1—melanoma	4.04e-05	0.00022	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FN1—melanoma	4.02e-05	0.000219	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.98e-05	0.000217	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOTCH1—melanoma	3.94e-05	0.000214	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	3.93e-05	0.000214	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKT3—melanoma	3.91e-05	0.000212	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CTNNB1—melanoma	3.86e-05	0.00021	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CD80—melanoma	3.86e-05	0.00021	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APC—melanoma	3.85e-05	0.000209	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CG—melanoma	3.85e-05	0.000209	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KIT—melanoma	3.85e-05	0.000209	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GNA11—melanoma	3.81e-05	0.000207	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EGF—melanoma	3.81e-05	0.000207	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PRKCA—melanoma	3.74e-05	0.000203	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—FASN—melanoma	3.73e-05	0.000203	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ERCC2—melanoma	3.71e-05	0.000202	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—AKT1—melanoma	3.71e-05	0.000202	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLC5A5—melanoma	3.67e-05	0.0002	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—BRAF—melanoma	3.62e-05	0.000197	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GNAQ—melanoma	3.54e-05	0.000193	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CD44—melanoma	3.54e-05	0.000193	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IGF1—melanoma	3.53e-05	0.000192	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.47e-05	0.000189	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ERBB4—melanoma	3.45e-05	0.000188	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDKN2B—melanoma	3.42e-05	0.000186	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAP2K1—melanoma	3.41e-05	0.000185	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP1B1—melanoma	3.4e-05	0.000185	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CD—melanoma	3.39e-05	0.000184	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MAPK3—melanoma	3.35e-05	0.000182	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD86—melanoma	3.31e-05	0.00018	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MYC—melanoma	3.26e-05	0.000177	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGF2—melanoma	3.24e-05	0.000176	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGF1—melanoma	3.21e-05	0.000174	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PDGFRA—melanoma	3.11e-05	0.000169	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PRKCA—melanoma	3.08e-05	0.000167	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.07e-05	0.000167	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ERCC2—melanoma	3.05e-05	0.000166	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MDM2—melanoma	3.03e-05	0.000165	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MAP2K2—melanoma	3.01e-05	0.000163	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	3e-05	0.000163	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ERBB2—melanoma	2.99e-05	0.000163	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CB—melanoma	2.95e-05	0.00016	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CG—melanoma	2.93e-05	0.000159	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HLA-A—melanoma	2.86e-05	0.000155	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TERT—melanoma	2.86e-05	0.000155	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RAC1—melanoma	2.85e-05	0.000155	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL8—melanoma	2.84e-05	0.000154	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPARG—melanoma	2.83e-05	0.000154	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ABCB1—melanoma	2.8e-05	0.000152	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDKN1B—melanoma	2.77e-05	0.000151	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HIF1A—melanoma	2.73e-05	0.000149	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CASP3—melanoma	2.71e-05	0.000148	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL2—melanoma	2.71e-05	0.000147	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCND1—melanoma	2.64e-05	0.000144	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CTNNB1—melanoma	2.62e-05	0.000142	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CD—melanoma	2.58e-05	0.00014	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PRKCA—melanoma	2.58e-05	0.00014	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MMP9—melanoma	2.56e-05	0.000139	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDKN1A—melanoma	2.56e-05	0.000139	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ERCC2—melanoma	2.55e-05	0.000139	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MAPK3—melanoma	2.55e-05	0.000139	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTEN—melanoma	2.55e-05	0.000139	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALB—melanoma	2.54e-05	0.000138	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NFKB1—melanoma	2.54e-05	0.000138	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS2—melanoma	2.49e-05	0.000135	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MYC—melanoma	2.48e-05	0.000135	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOTCH1—melanoma	2.46e-05	0.000134	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD80—melanoma	2.41e-05	0.000131	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APC—melanoma	2.41e-05	0.000131	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KIT—melanoma	2.41e-05	0.000131	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EGF—melanoma	2.38e-05	0.000129	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—VEGFA—melanoma	2.3e-05	0.000125	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—STAT3—melanoma	2.28e-05	0.000124	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NRAS—melanoma	2.27e-05	0.000124	CbGpPWpGaD
Drospirenone—PTGS2—Disease—BRAF—melanoma	2.26e-05	0.000123	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—AKT1—melanoma	2.26e-05	0.000123	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CB—melanoma	2.25e-05	0.000122	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTGS2—melanoma	2.23e-05	0.000121	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAPK3—melanoma	2.18e-05	0.000118	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MAP2K1—melanoma	2.13e-05	0.000116	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MYC—melanoma	2.12e-05	0.000115	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CD—melanoma	2.12e-05	0.000115	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.12e-05	0.000115	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAPK1—melanoma	2.07e-05	0.000113	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EGFR—melanoma	2.07e-05	0.000113	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGF2—melanoma	2.03e-05	0.00011	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CG—melanoma	2.02e-05	0.00011	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KRAS—melanoma	1.96e-05	0.000106	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPARG—melanoma	1.95e-05	0.000106	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTEN—melanoma	1.94e-05	0.000106	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MDM2—melanoma	1.9e-05	0.000103	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ERBB2—melanoma	1.87e-05	0.000102	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CB—melanoma	1.85e-05	0.0001	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD4—melanoma	1.84e-05	0.0001	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CA—melanoma	1.8e-05	9.78e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CD—melanoma	1.77e-05	9.64e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALB—melanoma	1.75e-05	9.52e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TP53—melanoma	1.74e-05	9.46e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDKN1B—melanoma	1.73e-05	9.42e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—AKT1—melanoma	1.72e-05	9.36e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HRAS—melanoma	1.66e-05	9.05e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CTNNB1—melanoma	1.64e-05	8.9e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDKN1A—melanoma	1.6e-05	8.69e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PTEN—melanoma	1.59e-05	8.67e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6—melanoma	1.59e-05	8.66e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CB—melanoma	1.55e-05	8.4e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKT1—melanoma	1.47e-05	7.99e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—STAT3—melanoma	1.43e-05	7.76e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NRAS—melanoma	1.42e-05	7.74e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CA—melanoma	1.37e-05	7.44e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MAPK3—melanoma	1.36e-05	7.41e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PTEN—melanoma	1.34e-05	7.26e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MYC—melanoma	1.33e-05	7.21e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MAPK1—melanoma	1.3e-05	7.05e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EGFR—melanoma	1.3e-05	7.05e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KRAS—melanoma	1.22e-05	6.66e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CA—melanoma	1.13e-05	6.12e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKT1—melanoma	1.12e-05	6.08e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HRAS—melanoma	1.04e-05	5.66e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6—melanoma	9.96e-06	5.42e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CA—melanoma	9.42e-06	5.12e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKT1—melanoma	9.19e-06	5e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKT1—melanoma	7.7e-06	4.19e-05	CbGpPWpGaD
